Catalyst Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
CPRX
CUSIP
14888U101
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 14888U101 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 13.9% 4/28/2025
Event 3/31/2025
State Street Corp 13G 5.2% 11/10/2025
Event 9/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
James E. Flynn 13G/A
2.6% 2/13/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 1.53 k $48.2 k
2026 Q2 405 112 M $3.51 B
2026 Q1 394 105 M $2.59 B
2025 Q4 383 104 M $2.43 B
2025 Q3 373 104 M $2.04 B
2025 Q2 374 102 M $2.21 B
2025 Q1 381 98.4 M $2.39 B
2024 Q4 344 97.8 M $2.04 B
2024 Q3 324 96.0 M $1.91 B
2024 Q2 283 98.3 M $1.52 B
2024 Q1 278 100 M $1.60 B
2023 Q4 267 87.8 M $1.48 B
2023 Q3 265 81.5 M $953 M
2023 Q2 261 82.4 M $1.11 B
2023 Q1 275 89.1 M $1.48 B
2022 Q4 274 92.1 M $1.71 B
2022 Q3 242 85.2 M $1.09 B
2022 Q2 197 75.8 M $532 M
2022 Q1 196 70.9 M $587 M
2021 Q4 172 66.3 M $449 M
2021 Q3 151 65.2 M $345 M
2021 Q2 147 65.5 M $377 M
2021 Q1 142 67.7 M $312 M
2020 Q4 149 68.3 M $228 M
2020 Q3 152 67.9 M $202 M
2020 Q2 147 64.7 M $299 M
2020 Q1 141 65.9 M $254 M
2019 Q4 138 64.3 M $241 M
2019 Q3 125 61.7 M $328 M
2019 Q2 114 61.8 M $237 M
2019 Q1 95 62.5 M $319 M
2018 Q4 89 50.2 M $96.4 M
2018 Q3 107 51.8 M $196 M
2018 Q2 103 54.5 M $170 M
2018 Q1 101 55.5 M $133 M
2017 Q4 108 56.1 M $219 M
2017 Q3 84 35.6 M $89.7 M
2017 Q2 73 33.9 M $93.7 M
2017 Q1 55 25.4 M $49.4 M
2016 Q4 56 23.9 M $25.0 M
2016 Q3 51 23.3 M $25.4 M
2016 Q2 63 25.4 M $18.0 M
2016 Q1 74 37.0 M $43.2 M
2015 Q4 89 42.5 M $104 M
2015 Q3 92 45.6 M $137 M
2015 Q2 90 43.5 M $180 M
2015 Q1 69 38.9 M $168 M
2014 Q4 52 27.5 M $81.3 M
2014 Q3 60 23.8 M $78.7 M
2014 Q2 53 24.8 M $62.8 M
2014 Q1 41 10.5 M $23.7 M